Indo Us Biotech Limited

Fast Moving Consumer Goods · Agricultural Food & other Products

NSE: INDOUS BSE: 541304
₹78.22
▲ 0.80 (1.03%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
60/100
Moderate
Valuation
86/100
Undervalued
Momentum
48/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹157 Cr
PE (TTM)
13.7
Industry median 20.0 (105 companies)
Price to Book
1.7
PEG (TTM)
-0.5
Institutions holding %
Data unavailable.
Piotroski Score
3
Relative return vs Nifty50, qtr %
-2.1
Relative return vs Sector, qtr %
-3.5
Free Cash Flow
₹-14 Cr
as of March 31, 2026
Industry median ₹-1 Cr (170 companies)
EPS Growth (YoY)
-35.74%
as of June 30, 2026
Industry median 0.00% (144 companies)
Net Profit Growth (TTM)
-6.53%
as of June 30, 2026
Industry median 11.37% (141 companies)
Operating Revenue Growth (TTM)
1.45%
as of June 30, 2026
Industry median 2.68% (143 companies)
Profit Growth (YoY)
-35.41%
as of June 30, 2026
Industry median 8.27% (143 companies)
Revenue Growth (YoY)
7.21%
as of June 30, 2026
Industry median 5.85% (130 companies)
Current Ratio
3.05
as of March 31, 2026
Industry median 1.58 (167 companies)
Debt to Equity
0.40
as of March 31, 2026
Industry median 0.35 (152 companies)
Interest Coverage
5.81
as of June 30, 2026
Industry median 2.71 (143 companies)
Net Margin
9.21%
as of June 30, 2026
Industry median 4.64% (134 companies)
Operating Margin (EBIT)
11.57%
as of June 30, 2026
Industry median 5.80% (138 companies)
Operating Margin (TTM)
13.06%
as of June 30, 2026
Industry median 4.65% (145 companies)
Return on Assets
12.17%
as of March 31, 2026
Industry median 2.70% (146 companies)
Return on Capital Employed
17.27%
as of March 31, 2026
Industry median 8.38% (145 companies)
Return on Equity
17.51%
as of March 31, 2026
Industry median 6.62% (146 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 3)
  • Yes Debt to equity is below 0.5 (0.40)
  • Yes Return on equity is 15% or more (17.5%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 4 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.0%
Low 75.5100 · High 81.9800
1W return
0.2%
Low 75.5100 · High 81.9800
1M return
-1.6%
Low 70.0000 · High 84.2700
52W return
-43.1%
Low 70.0000 · High 159.0000
Lifetime High ₹376.1000 (Dec. 11, 2024)
Lifetime Low ₹77.1600 (Sept. 16, 2026)

Full price history and technicals →

EMA & SMA

Bullish2
Bearish4
5D
78.0
10D
78.1
20D
78.8
50D
81.7
100D
88.2
200D
102.6

Delivery and volume

Day avg. delivery
90.6%
Week avg. delivery
58.7%
Month avg. delivery
73.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

78.57
Pivot
First resistance81.63
Second resistance85.04
Third resistance88.10
First support75.16
Second support72.10
Third support68.69
Day RSI44.9
Day MFI57.1
Day MACD-1.01
Day MACD signal-1.15

Beta

1M-0.54
3M-0.02
1Y0.90
3Y0.88

Price change analysis

↓ -1.6%
Over 1 Month
LowHigh
70.0084.27
↓ -11.6%
Over 3 Months
LowHigh
70.0091.90
↓ -23.1%
Over 6 Months
LowHigh
70.00114.00
↓ -43.1%
Over 1 Year
LowHigh
70.00159.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 13.7 (own history: 15.0–37.0)
Undervalued (below its own historical PE range)
Revenue (June 30, 2026)
₹33 Cr
Net profit (June 30, 2026)
₹3 Cr
Basic EPS (June 30, 2026)
₹1.5100

Ranks #70 of 152 in Agricultural Food & other Products by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter68.29%
  • FII/FPI0.01%

Largest holders

NameCategoryShares %Shares
JAGDISHKUMAR DEVJIBHAI AJUDIYAPromoter48.8200%9788924
INDO US AGRISEEDS LIMITEDPromoter8.8200%1769569
AJUDIA JAGDISH DEVJIBHAI HUFPromoter5.7400%1150028
MALTI JAGDISHBHAI AJUDIAPromoter2.9100%584122
PRIYANKA JAGDISHBHAI AJUDIAPromoter1.9900%400000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 68.29% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 0.18% to 0.01% in Jun 2026 qtr

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 6 insider trades, 6 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
5 Mar 2026 INDO US AGRISEEDS LIMITED Promoter group Sell 0 ₹0
18 Feb 2026 INDO US AGRISEEDS LIMITED Promoter group Sell 0 ₹0
12 Feb 2026 INDO US AGRISEEDS LIMITED Promoter group Sell 0 ₹0
11 Feb 2026 INDO US AGRISEEDS LIMITED Promoter group Sell 0 ₹0
10 Feb 2026 INDO US AGRISEEDS LIMITED Promoter group Sell 0 ₹0
9 Feb 2026 INDO US AGRISEEDS LIMITED Promoter group Sell 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
6 Mar 2026 SHAH DALPATLAL NITIN Bulk Sell 138,661 114.1800 NSE
6 Mar 2026 SHAH DALPATLAL NITIN Bulk Sell 138,661 114.1800 NSE
12 Jul 2022 SHALIN SHAH . Bulk Buy 37,500 77.7700 BSE
24 Mar 2021 SANGITA PRAVINKUMAR TUNDIYA Bulk Sell 35,000 40.7500 BSE
24 Mar 2021 NATVARSINH T CHAVDA . Bulk Buy 42,500 35.7400 BSE
25 Nov 2020 INDO US AGRISEEDS PRIVATE LIMITED Bulk Buy 50,000 49.6800 BSE
22 Sep 2020 INDO US AGRISEEDS PRIVATE LIMITED Bulk Buy 41,250 49.8500 BSE
21 Sep 2020 INDO US AGRISEEDS PRIVATE LIMITED Bulk Buy 58,750 49.7400 BSE
8 Nov 2019 JAGRUTIBEN C SHAH Bulk Buy 35,000 76.4600 BSE
23 Jul 2019 RAMESHBHAI SHAMBHUBHAI DOMADIYA Bulk Sell 50,000 89.6500 BSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
3 Dec 2024 Interim Dividend - Rs 0.25 Per Share 0.2500 3 Dec 2024

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
12 Aug 2026 Financial Results Yes
29 May 2026 Financial Results Yes
21 Jan 2026 Financial Results Yes
14 Nov 2025 Financial Results Yes
14 Oct 2025 Other business matters —

Corporate Announcements

All 133 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
2 Oct 2026 AGM/EGM Indo Us Bio-Tech Ltd - 541304 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
2 Oct 2026 Shareholders meeting Indo Us Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
30 Sep 2026 AGM/EGM Indo Us Bio-Tech Ltd - 541304 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Shareholders meeting Indo Us Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
28 Sep 2026 Insider Trading / SAST Indo Us Bio-Tech Ltd - 541304 - Closure of Trading Window
28 Sep 2026 Trading Window Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
6 Sep 2026 Company Update Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Newspaper Publication
6 Sep 2026 Copy of Newspaper Publication Indo Us Biotech Limited has informed the Exchange about Copy of Newspaper Publication
5 Sep 2026 AGM/EGM Indo Us Bio-Tech Ltd - 541304 - Intimation Of Book Closure For The Purpose Of 22Nd AGM Pursuant To Regulation 42 Of SEBI (LODR)
5 Sep 2026 AGM/EGM Indo Us Bio-Tech Ltd - 541304 - Shareholder Meeting- AGM On Sep 30, 2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Declining profit YoY (-35.4%)

Opportunities

  • PE below 15 (13.7) relative to a typical growth business

Threats

  • Down 43.1% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Indo Us Biotech Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.